Half-year report · Q2

Period2024-04-01 → 2024-09-30
Filed2024-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥85.6bn2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥179.4bn2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥85.0bn2023-04-01 → 2023-09-30Cons.Net sales
Operating income¥4.3bn2024-04-01 → 2024-09-30Cons.Operating income
Operating income¥5.0bn2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income¥5.4bn2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥16.1bn2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥6.3bn2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax¥4.8bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥6.5bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)¥2.3bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥10.8bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥4.3bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income¥2.3bn2024-04-01 → 2024-09-30Cons.Profit loss
Net income¥4.3bn2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥316.8bnat 2024-09-30Cons.Assets
Total assets¥337.5bnat 2024-03-31Cons.Assets
Total assets¥360.5bnat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥99.1bnat 2024-09-30Cons.Liabilities
Total liabilities¥100.6bnat 2024-03-31Cons.Liabilities
Net assets / equity¥217.7bnat 2024-09-30Cons.Net assets
Net assets / equity¥237.0bnat 2024-03-31Cons.Net assets
Net assets / equity¥248.6bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥57.0bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥65.7bnat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥55.4bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥62.5bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥67.6bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥57.5bnat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow¥7.3bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥9.0bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.3bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥6.8bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow¥5.4bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥2.5bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥5.7bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥13.5bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥7.6bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥22.952024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥97.222023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥36.922023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio68.7%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio70.2%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio69.0%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 61
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-04-01 → 2024-09-30¥632m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-04-01 → 2024-09-30¥625m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2024-04-01 → 2024-09-30¥6m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-04-01 → 2024-09-30¥33m
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-09-30−¥13m
Reconciling Itemsreconcilingrevenue intersegment2024-04-01 → 2024-09-30−¥13m
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30−¥48m
jpcrp040300-q2r_E01929-000Industrial Processesreportable segmentrevenue2024-04-01 → 2024-09-30¥37.6bn
jpcrp040300-q2r_E01929-000Industrial Processesreportable segmentrevenue external2024-04-01 → 2024-09-30¥37.6bn
jpcrp040300-q2r_E01929-000Industrial Processesreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥2m
jpcrp040300-q2r_E01929-000Industrial Processesreportable segmentsegment profit2024-04-01 → 2024-09-30¥5.2bn
jpcrp040300-q2r_E01929-000Life Sciencesreportable segmentrevenue2024-04-01 → 2024-09-30¥3.1bn
jpcrp040300-q2r_E01929-000Life Sciencesreportable segmentrevenue external2024-04-01 → 2024-09-30¥3.0bn
jpcrp040300-q2r_E01929-000Life Sciencesreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥1m
jpcrp040300-q2r_E01929-000Life Sciencesreportable segmentsegment profit2024-04-01 → 2024-09-30−¥554m
jpcrp040300-q2r_E01929-000Photonics Solutionsreportable segmentrevenue2024-04-01 → 2024-09-30¥5.1bn
jpcrp040300-q2r_E01929-000Photonics Solutionsreportable segmentrevenue external2024-04-01 → 2024-09-30¥5.1bn
jpcrp040300-q2r_E01929-000Photonics Solutionsreportable segmentsegment profit2024-04-01 → 2024-09-30−¥281m
jpcrp040300-q2r_E01929-000Visual Imagingreportable segmentrevenue2024-04-01 → 2024-09-30¥39.3bn
jpcrp040300-q2r_E01929-000Visual Imagingreportable segmentrevenue external2024-04-01 → 2024-09-30¥39.3bn
jpcrp040300-q2r_E01929-000Visual Imagingreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥2m
jpcrp040300-q2r_E01929-000Visual Imagingreportable segmentsegment profit2024-04-01 → 2024-09-30−¥120m
—segment totalrevenue2024-04-01 → 2024-09-30¥85.0bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥85.0bn
—segment totalrevenue intersegment2024-04-01 → 2024-09-30¥6m
—segment totalsegment profit2024-04-01 → 2024-09-30¥4.3bn
Total Of Reportable Segments And Otherssegment totalrevenue2024-04-01 → 2024-09-30¥85.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-04-01 → 2024-09-30¥85.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2024-04-01 → 2024-09-30¥13m
Total Of Reportable Segments And Otherssegment totalsegment profit2024-04-01 → 2024-09-30¥4.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-09-30¥630m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-09-30¥617m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-04-01 → 2023-09-30¥13m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-09-30−¥120m
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥32m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥32m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30¥38m
jpcrp040300-q2r_E01929-000Industrial Processesreportable segmentrevenue2023-04-01 → 2023-09-30¥37.8bn
jpcrp040300-q2r_E01929-000Industrial Processesreportable segmentrevenue external2023-04-01 → 2023-09-30¥37.8bn
jpcrp040300-q2r_E01929-000Industrial Processesreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥5m
jpcrp040300-q2r_E01929-000Industrial Processesreportable segmentsegment profit2023-04-01 → 2023-09-30¥3.9bn
jpcrp040300-q2r_E01929-000Life Sciencesreportable segmentrevenue2023-04-01 → 2023-09-30¥2.7bn
jpcrp040300-q2r_E01929-000Life Sciencesreportable segmentrevenue external2023-04-01 → 2023-09-30¥2.7bn
jpcrp040300-q2r_E01929-000Life Sciencesreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥1m
jpcrp040300-q2r_E01929-000Life Sciencesreportable segmentsegment profit2023-04-01 → 2023-09-30−¥1.2bn
jpcrp040300-q2r_E01929-000Photonics Solutionsreportable segmentrevenue2023-04-01 → 2023-09-30¥5.1bn
jpcrp040300-q2r_E01929-000Photonics Solutionsreportable segmentrevenue external2023-04-01 → 2023-09-30¥5.1bn
jpcrp040300-q2r_E01929-000Photonics Solutionsreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥6m
jpcrp040300-q2r_E01929-000Photonics Solutionsreportable segmentsegment profit2023-04-01 → 2023-09-30−¥703m
jpcrp040300-q2r_E01929-000Visual Imagingreportable segmentrevenue2023-04-01 → 2023-09-30¥38.9bn
jpcrp040300-q2r_E01929-000Visual Imagingreportable segmentrevenue external2023-04-01 → 2023-09-30¥38.9bn
jpcrp040300-q2r_E01929-000Visual Imagingreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥5m
jpcrp040300-q2r_E01929-000Visual Imagingreportable segmentsegment profit2023-04-01 → 2023-09-30¥3.0bn
—segment totalrevenue2023-04-01 → 2023-09-30¥84.4bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥84.4bn
—segment totalrevenue intersegment2023-04-01 → 2023-09-30¥19m
—segment totalsegment profit2023-04-01 → 2023-09-30¥5.1bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥85.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥85.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-09-30¥32m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥4.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 604
ItemContextValueUnit
Net increase decrease in cash and cash equivalentsPrior1YTDDuration10056000000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration-7142000000JPY
Cash and cash equivalentsPrior2YearInstant57516000000JPY
Cash and cash equivalentsPrior1YearInstant62498000000JPY
Cash and cash equivalentsPrior1QuarterInstant67572000000JPY
Cash and cash equivalentsCurrentQuarterInstant55355000000JPY
Salaries and allowances sgaPrior1YTDDuration7157000000JPY
Salaries and allowances sgaCurrentYTDDuration7767000000JPY
Provision for bonuses sgaPrior1YTDDuration897000000JPY
Provision for bonuses sgaCurrentYTDDuration876000000JPY
Provision for directors bonuses sgaPrior1YTDDuration39000000JPY
Provision for directors bonuses sgaCurrentYTDDuration22000000JPY
Retirement benefit expenses sgaPrior1YTDDuration247000000JPY
Retirement benefit expenses sgaCurrentYTDDuration109000000JPY
Provision for directors retirement benefits sgaPrior1YTDDuration-22000000JPY
Provision for directors retirement benefits sgaCurrentYTDDuration1000000JPY
Provision for share based remuneration for directors and other officers sgaPrior1YTDDuration65000000JPY
Provision for share based remuneration for directors and other officers sgaCurrentYTDDuration14000000JPY
Research and development expenses sgaPrior1YTDDuration6405000000JPY
Research and development expenses sgaCurrentYTDDuration6969000000JPY
Provision of allowance for doubtful accounts sgaPrior1YTDDuration121000000JPY
Provision of allowance for doubtful accounts sgaCurrentYTDDuration22000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E01929-000IndustrialProcessesReportableSegmentsMember37782000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E01929-000VisualImagingReportableSegmentsMember38854000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E01929-000LifeSciencesReportableSegmentsMember2688000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E01929-000PhotonicsSolutionsReportableSegmentsMember5060000000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember84385000000JPY
Revenues from external customersPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember617000000JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember85003000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember-JPY
Revenues from external customersPrior1YTDDuration85003000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E01929-000IndustrialProcessesReportableSegmentsMember5000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E01929-000VisualImagingReportableSegmentsMember5000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E01929-000LifeSciencesReportableSegmentsMember1000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E01929-000PhotonicsSolutionsReportableSegmentsMember6000000JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember19000000JPY
Transactions with other segmentsPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember13000000JPY
Transactions with other segmentsPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember32000000JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-32000000JPY
Transactions with other segmentsPrior1YTDDuration-JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E01929-000IndustrialProcessesReportableSegmentsMember37788000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E01929-000VisualImagingReportableSegmentsMember38859000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E01929-000LifeSciencesReportableSegmentsMember2690000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E01929-000PhotonicsSolutionsReportableSegmentsMember5066000000JPY
Net salesPrior1YTDDuration_ReportableSegmentsMember84405000000JPY
Net salesPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember630000000JPY
Net salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember85035000000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember-32000000JPY
Net salesPrior1YTDDuration85003000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E01929-000IndustrialProcessesReportableSegmentsMember3947000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass
balance sheet identityconsolidated 2024-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass